Preferred Name |
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose |
|
Synonyms |
|
|
ID |
http://purl.bioontology.org/ontology/HCPCS/M0250 |
|
cui |
C5574599 |
|
HAC |
N=No maintenance for this code |
|
HAD |
20210624 |
|
HAQ |
0 |
|
HBT |
O1G=Immunizations/Vaccinations |
|
HCC |
C=Carrier judgment |
|
HCD |
20210624 |
|
HMP |
A=Not applicable as HCPCS priced under one methodology |
|
HPI |
54=Vaccinations |
|
HTS |
V=Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
|
notation |
M0250 |
|
prefLabel |
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose |
|
tui |
T061 |
|
subClassOf |
http://purl.bioontology.org/ontology/HCPCS/Level%201%3A%20M0000-M1210 |